Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
MARKSANS | BSE
1.70
1.07%
Healthcare
Drug Manufacturers-General
30/09/2023
08/12/2023
161.10
159.55
162.30
157.80
Marksans Pharma Limited together with its subsidiaries engages in the research and development manufacturing marketing distribution and sale of generic pharmaceutical formulations worldwide. The company offers products in the analgesics benign prostatic hyperplasia antidiabetic epilepsy anti-inflammatory hyperparathyroidism diabetes antacids neurology cardiovascular hormonal oncology gastroenterology antidiabetic pain management gynecology antibiotic antifungal antiulceratives vitamins dermatology cephalosporins injectables anti-allergy antibacterial and hypertension therapeutic areas. It also provides contract research and manufacturing services. Marksans Pharma Limited was incorporated in 1992 and is headquartered in Mumbai India.
View LessLow Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
Strong Revenue Growth (> 10%)
Strong Sharpe Ratio (> 1.2)
High Short-term Volatility
Smallcap (300M - 2B USD)
High Market Beta (> 0.8)
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
10 days
72.7%1 month
62.4%3 months
46.0%6 months
45.1%24.44
0
3.80
0.06
0.05
14.29
3.29
0
3.83B
72.01B
863.30M
0.30
18.15
21.10
17.40
18.83
0
0
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
Range10D
32.30
Range1M
58.30
Range3M
78.15
Rel. volume
0.28
Price X volume
22.60M